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Th   e American comedian Rodney Dangerﬁ  eld was famous 
for his catch phrase ‘I don’t get no respect’, which he used 
to punctuate monologues throughout an illustrious 
career. Th   e fulcrum of humor on topics such as drinking, 
sex and marriage, the phrase ﬁ   t well the persona of 
Dangerﬁ  eld.  Th  is was a man whose appearance dis-
respected respect. His eyes bulged, he was nervous and 
jittery and he constantly tugged at his collar and wiped 
sweat from his brow. It seemed that, no matter what 
Dangerﬁ  eld did, respect would keep far from his way.
Biological ﬂ  uids do not speak (or do stand-up) but, if 
they did, pus would be the Rodney Dangerﬁ  eld  of 
immunology, deﬁ  nitely complaining about its treatment. 
While arguably one of the most critical expressions of 
innate immunity - a veritable magic elixir to vanquish 
infection and decontaminate the most noxious debris - 
pus  per se does not appear to be the focus of many 
studies. Consider the following statistics. For the year 
2010, Medline lists 259 citations with pus as a key word. 
In contrast, exudate had 412 citations and eﬀ  usion had 
1,525. I could not ﬁ  nd one reference ever published on 
the pus proteome.
Not only is pus uncommonly a research topic but 
investigators do not seem to want to identify themselves 
with this ﬂ  uid. Who is the world’s pus expert? I do not 
know anyone who has embraced this distinction. Th  e 
situation is not surprising since pus is not the most 
pleasant material in the world. It is thick, slimy and 
gooey - indeed, downright yucky. Th   e color is disgusting 
unless you like a vile mélange of yellow, green and brown. 
And the stuﬀ    often stinks. Even though it is readily 
accessible in the clinic and ward - an easily sampled 
bonanza for biomarker development and translational 
research - investigators turn their heads (and noses) away 
when pus is around.
Times may be changing, however, and pus may ﬁ  nally 
be attracting the attention and respect that it deserves. 
Th  e impetus for such change has been the discovery of 
one of the most ingenious systems for host defense that 
the immune system deploys. Th  is system has been 
termed NETs, an acronym that stands for neutrophil 
extracellular traps. In simplest form, NETs represent the 
DNA from a neutrophil that has been extruded into the 
extracellular space by a unique mechanism called 
NETosis. In NETosis, certain activating inﬂ  uences can 
trigger a cellular transformation in which the nuclear 
membrane breaks down, DNA mixes with cytoplasm and 
the whole assemblage is jettisoned from the cell, 
providing a key ingredient for pus and other exudates 
(Figure 1). Depleted of its DNA, the neutrophil cannot 
survive and NETosis is as much a form of cell death as 
cell activation, albeit speciﬁ  c for neutrophils [1-3].
While an expression of innate immune activation, 
NETs are unlike any other weapon in the arsenal of host 
defense since they represent a physical structure to 
ensnare and immobilize bacteria and other micro-
organisms in a mesh or net-like structure. Like a ﬂ  y in a 
spider’s web, the organisms are stuck and can be further 
attacked by the antibacterial proteins that stud the DNA 
[1-3]. Interestingly, histones have anti-bacterial activity, 
providing another example of a nuclear molecule doing 
double duty for the cell, fulﬁ  lling important functions in 
both the intracellular and extracellular space [4].
In addition to their function in the defense against 
infection, NETs may contribute to the pathogenesis of 
rheumatic disease. NETs are present at sites of tissue 
injury in vasculitis, promote thrombosis (an important 
concomitant of many connective tissue diseases) and 
represent an important source of DNA to form immune 
complexes and drive type I interferon production [5-9]. 
Th  e role of extracellular DNA and RNA in immuno-
pathogenesis is a booming ﬁ  eld, leading to exploration of 
new biomarkers (that is, blood nucleome) as well as 
targets of therapy (for example, Toll-like receptor 
ligands). Certainly, it will be interesting to explore the 
eﬀ   ects on NETs formation of glucocorticoids whose 
eﬀ   ects on neutrophils have long been recognized but 
remain poorly understood.
Given the physical properties of pus, the existence of 
NETs should not have been unexpected. High molecular 
weight polymers like DNA confer viscosity and pus is 
very viscous. Th  e obvious questions to be asked were 
‘Why is pus viscous?’ and ‘Is viscosity important to the 
activity of pus?’ In a sense, some physicians appreciated 
the importance of viscosity long ago since they  © 2010 BioMed Central Ltd
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© 2011 BioMed Central Ltddis  tin  guished pus by its quality, with thick pus good and 
thin pus bad. With current understanding, it appears that 
good pus has NETs while bad pus lacks these structures, 
whether by inadequate production or excessive degradation.
While the biology of NETs will only grow in interest, it 
is remarkable that such fascinating biology was neglected 
until recently. If Rodney Dangerﬁ  eld were an immuno-
logist instead of a comedian, I know his take on the 
situation. With frustration and exasperation, he would 
have sputtered, ‘I tell ya, pus don’t get no respect.’ And, 
he would have been right.
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Figure 1. A schematic representation of the formation of a NET (neutrophil extracellular trap) and its killing of a bacterium. With 
activation, the nuclear membrane of a neutrophil breaks down, allowing mixing of the nuclear contents with cytoplasmic proteins to form a NET. 
The resulting NET leaves the cell to serve as an extracellular mesh to trap bacteria, which are induced to die by the anti-bacterial action of histones 
and bacteriocidal cytoplasmic proteins in the NET. The Latin cross signifi  es cell death of a bacterium. TLR, Toll-like receptor.
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